US Stock MarketDetailed Quotes

INM InMed Pharmaceuticals

Watchlist
  • 4.9500
  • +0.4500+10.00%
Close Jan 17 16:00 ET
  • 4.8800
  • -0.0700-1.41%
Pre 06:05 ET
3.58MMarket Cap-0.65P/E (TTM)

InMed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

InMed Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q31.601M / 2.005M--
--2024/Q21.682M / 1.518M--
--2024/Q11.243M / 1.895M--
--2023/Q43.126M / 3.039M--
Sep 23, 20222022/Q4698.290K / 969.890K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q31.601M / 2.005M--
--2024/Q21.682M / 1.518M--
--2024/Q11.243M / 1.895M--
--2023/Q43.126M / 3.039M--
Sep 23, 20222022/Q4698.290K / 969.890K--

Unlock Free Earnings Estimates

InMed Pharmaceuticals Earnings Reports

  • InMed Pharmaceuticals | 8-K: InMed Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update

    Nov 15, 2024 11:28 ET

  • InMed Pharmaceuticals | 10-Q: Q1 2025 Earnings Report

    Nov 14, 2024 16:22 ET

  • InMed Pharmaceuticals | 10-K: FY2024 Annual Report

    Sep 30, 2024 12:40 ET

  • InMed Pharmaceuticals | 8-K: InMed Pharmaceuticals Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update

    May 14, 2024 16:24 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Hutchmed (China)
    HCM
    +6.61%
    Ermenegildo Zegna NV
    ZGN
    +2.34%
    New Fortress Energy
    NFE
    +2.32%
    Enerpac Tool
    EPAC
    +1.91%
    eBay
    EBAY
    +1.74%

    Unlock the Full List

    Investment Theme Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-0.79%